Cargando…
The first study in pediatric: Population pharmacokinetics of sirolimus and its application in Chinese children with immune cytopenia
The narrow therapeutic index and large inter-individual variability in sirolimus pharmacokinetics (PK) make therapeutic drug monitoring (TDM) necessary. Factors responsible for PK variability are not well understood, and published PK studies do not include pediatric patients with immune cytopenia. T...
Autores principales: | Cheng, Xiaoling, Zhao, Yiming, Gu, Hao, Zhao, Libo, Zang, Yannan, Wang, Xiaoling, Wu, Runhui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388097/ https://www.ncbi.nlm.nih.gov/pubmed/32720540 http://dx.doi.org/10.1177/2058738420934936 |
Ejemplares similares
-
Case Report: Sirolimus Alleviates Persistent Cytopenia After CD19 CAR-T-Cell Therapy
por: Xing, Limin, et al.
Publicado: (2021) -
Various phenotypes of LRBA gene with compound
heterozygous variation: A case series report of pediatric cytopenia
patients
por: Yao, Jiafeng, et al.
Publicado: (2022) -
Efficacy and safety of eltrombopag in the treatment of severe chronic immune thrombocytopenia in children of China: A single-center observational study
por: Cheng, Xiaoling, et al.
Publicado: (2019) -
Population pharmacokinetics of sirolimus in pediatric patients with kaposiform hemangioendothelioma: A retrospective study
por: Wang, Dongdong, et al.
Publicado: (2019) -
Sirolimus Pharmacokinetics Variability Points to the Relevance of Therapeutic Drug Monitoring in Pediatric Oncology
por: Sabo, Amelia-Naomi, et al.
Publicado: (2021)